Renaissance Technologies’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-326,622
Closed -$2.73M 4024
2023
Q3
$2.73M Buy
+326,622
New +$2.73M ﹤0.01% 1683
2022
Q3
Sell
-114,200
Closed -$505K 4322
2022
Q2
$505K Sell
114,200
-754,500
-87% -$3.34M ﹤0.01% 3162
2022
Q1
$7.91M Buy
+868,700
New +$7.91M 0.01% 1281
2021
Q4
Sell
-273,800
Closed -$7M 4140
2021
Q3
$7M Sell
273,800
-547,000
-67% -$14M 0.01% 1252
2021
Q2
$28.7M Buy
820,800
+37,300
+5% +$1.3M 0.04% 554
2021
Q1
$26.1M Buy
+783,500
New +$26.1M 0.03% 633
2018
Q1
Sell
-113,900
Closed -$301K 3518
2017
Q4
$301K Buy
+113,900
New +$301K ﹤0.01% 3024
2016
Q4
Sell
-374,900
Closed -$3.36M 3395
2016
Q3
$3.36M Sell
374,900
-29,164
-7% -$261K 0.01% 1870
2016
Q2
$2.84M Sell
404,064
-784,636
-66% -$5.52M 0.01% 1978
2016
Q1
$10.1M Sell
1,188,700
-397,700
-25% -$3.38M 0.02% 1130
2015
Q4
$20.8M Buy
+1,586,400
New +$20.8M 0.05% 526
2015
Q3
Sell
-309,500
Closed -$1.78M 3308
2015
Q2
$1.78M Buy
309,500
+184,300
+147% +$1.06M ﹤0.01% 2136
2015
Q1
$731K Sell
125,200
-12,772
-9% -$74.6K ﹤0.01% 2460
2014
Q4
$1.08M Buy
+137,972
New +$1.08M ﹤0.01% 2094
2014
Q2
Sell
-105,766
Closed -$566K 2916
2014
Q1
$566K Buy
+105,766
New +$566K ﹤0.01% 2310
2013
Q4
Sell
-280,100
Closed -$1.55M 2981
2013
Q3
$1.55M Buy
280,100
+4,100
+1% +$22.6K ﹤0.01% 1799
2013
Q2
$698K Buy
+276,000
New +$698K ﹤0.01% 2099